Advancell Efficacy
ADVANCELL in vitro systems are of special value to support marketing claims of efficacy and to provide insights into molecular mechanisms at an early stage.
You may also like
Trending Articles
You may also like
Ingredients
dsm-firmenich welcomes FDA proposal to expand US sunscreen actives, paving the way for PARSOL Shield
This proposal marks a historic milestone as it follows the first-ever Tier 1 OTC Monograph Order Request (OMOR) to be submitted to FDA – by dsm-firmenich - to amend OTC Monograph M020 and permit PARSOL® Shield at concentrations up to 6%